Brain regional thyroid hormone status and Dio3: where genetics, epigenetics and psychiatric vulnerability meet

References

• Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr. Rev.31(2), 139–170 (2010).
   PubMed Web of Science ®Google Scholar
• Guadaño-Ferraz A, Benavides-Piccione R, Venero C et al. Lack of thyroid hormone receptor α1 is associated with selective alterations in behavior and hippocampal circuits. Mol. Psychiatry8(1), 30–38 (2003).
   PubMed Web of Science ®Google Scholar
• Stone JM,Greenough WT. Excess neonatal thyroxine: effects on learning in infant and adolescent rats. Dev. Psychobiol.8(6), 479–488 (1975).
   PubMedGoogle Scholar
• Wilcoxon JS, Kuo AG, Disterhoft JF, Redei EE. Behavioral deficits associated with fetal alcohol exposure are reversed by prenatal thyroid hormone treatment: a role for maternal thyroid hormone deficiency in FAE. Mol. Psychiatry10(10), 961–971 (2005).
   PubMedGoogle Scholar
• Henrichs J, Bongers-Schokking JJ, Schenk JJ et al. Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study. J. Clin. Endocrinol. Metab.95(9), 4227–4234 (2010).
   PubMed Web of Science ®Google Scholar
• Gereben B, Zavacki AM, Ribich S et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr. Rev.29(7), 898–938 (2008).
   PubMed Web of Science ®Google Scholar
• Braun D, Kinne A, Bräuer AU et al. Developmental and cell type-specific expression of thyroid hormone transporters in the mouse brain and in primary brain cells. Glia59(3), 463–471 (2011).
   PubMed Web of Science ®Google Scholar
• Sugiyama D, Kusuhara H, Taniguchi H et al. Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood–brain barrier: high affinity transporter for thyroxine. J. Biol. Chem.278(44), 43489–43495 (2003).
   PubMed Web of Science ®Google Scholar
• Visser WE, Friesema EC, Jansen J, Visser TJ. Thyroid hormone transport in and out of cells. Trends Endocrinol. Metab.19(2), 50–56 (2008).
   PubMed Web of Science ®Google Scholar
• Guadaño-Ferraz A, Obregón MJ, St Germain DL, Bernal J. The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc. Natl Acad. Sci. USA94(19), 10391–10396 (1997).
   PubMed Web of Science ®Google Scholar
• Friesema EC, Kuiper GG, Jansen J, Visser TJ, Kester MH. Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Mol. Endocrinol.20(11), 2761–2772 (2006).
   PubMedGoogle Scholar
• Gereben B, Zeöld A, Dentice M, Salvatore D, Bianco AC. Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences. Cell. Mol. Life Sci.65(4), 570–590 (2008).
   PubMed Web of Science ®Google Scholar
• Hernandez A, Quignodon L, Martinez ME, Flamant F, St Germain DL. Type 3 deiodinase deficiency causes spatial and temporal alterations in brain T3 signaling that are dissociated from serum thyroid hormone levels. Endocrinology151(11), 5550–5558 (2010).
   PubMed Web of Science ®Google Scholar
• Shukla PK, Sittig LJ, Andrus BM, Schaffer DJ, Batra KK, Redei EE. Prenatal thyroxine treatment disparately affects peripheral and amygdala thyroid hormone levels. Psychoneuroendocrinology35(6), 791–797 (2010).
   PubMedGoogle Scholar
• Sittig LJ, Herzing LB, Shukla PK, Redei EE. Parent-of-origin allelic contributions to deiodinase-3 expression elicit localized hyperthyroid milieu in the hippocampus. Mol. Psychiatry16(8), 786–787 (2011).
   PubMedGoogle Scholar
• Hernandez A, Fiering S, Martinez E, Galton VA, St Germain D. The gene locus encoding iodothyronine deiodinase type 3 (Dio3) is imprinted in the fetus and expresses antisense transcripts. Endocrinology143(11), 4483–4486 (2002).
   PubMed Web of Science ®Google Scholar
• Hernandez A, Fiering S, Martinez E, Galton VA, St Germain D. Genomic imprinting contributes to thyroid hormone metabolism in the mouse embryo. Curr. Biol.12(14), 1221–1226 (2002).
   PubMedGoogle Scholar
• Edwards CA, Mungall AJ, Matthews L et al. The evolution of the DLK1-DIO3 imprinted domain in mammals. PLoS Biol.6(6), e135 (2008).
   Google Scholar
• Sittig LJ, Shukla PK, Herzing LB, Redei EE. Strain-specific vulnerability to alcohol exposure in utero via hippocampal parent-of-origin expression of deiodinase-III. FASEB J.25(7), 2313–2324 (2011).
   PubMedGoogle Scholar
• Labialle S, Yang L, Ruan X et al. Coordinated diurnal regulation of genes from the Dlk1-Dio3 imprinted domain: implications for regulation of clusters of non-paralogous genes. Hum. Mol. Genet.17(1), 15–26 (2008).
   PubMedGoogle Scholar
• Gregg C, Zhang J, Weissbourd B et al. High-resolution analysis of parent-of-origin allelic expression in the mouse brain. Science329(5992), 643–648 (2010).
   PubMed Web of Science ®Google Scholar
• Chamberlain SJ, Lalande M, Neurodevelopmental disorders involving genomic imprinting at human chromosome 15q11-q13. Neurobiol. Dis.39(1), 13–20 (2010).
   PubMedGoogle Scholar
• Kong A, Steinthorsdottir V, Masson G et al. Parental origin of sequence variants associated with complex diseases. Nature462(7275), 868–874 (2009).
   PubMed Web of Science ®Google Scholar
• Loosen PT. The TRH-induced TSH response in psychiatric patients: a possible neuroendocrine marker. Psychoneuroendocrinology10(3), 237–260 (1985).
   PubMedGoogle Scholar
• Bauer M, Goetz T, Glenn T, Whybrow PC et al. The thyroid–brain interaction in thyroid disorders and mood disorders. J. Neuroendocrinol.20(10), 1101–1114 (2008).
   PubMed Web of Science ®Google Scholar
• Redei EE, Solberg LC, Kluczynski JM, Pare WP et al. Paradoxical hormonal and behavioral responses to hypothyroid and hyperthyroid states in the Wistar–Kyoto rat. Neuropsychopharmacology24(6), 632–639 (2001).
   PubMedGoogle Scholar
• dos Reis-Lunardelli EA, Ramirez MR, Castro CC et al. Effects of an acute treatment with L-thyroxine on memory, habituation, danger avoidance, and on Na+, K+ -ATPase activity in rat brain. Curr. Neurovasc. Res.4(4), 259–267 (2007).
   PubMedGoogle Scholar
• Shelton RC, Osuntokun O, Heinloth AN, Corya SA. Therapeutic options for treatment-resistant depression. CNS Drugs24(2), 131–161 (2010).
   PubMed Web of Science ®Google Scholar
• Thase ME. Pharmacologic and therapeutic strategies in treatment-resistant depression. Augmentation strategies. CNS Spectr.14(3 Suppl 4), 7–10 (2009).
   PubMedGoogle Scholar
• Dixson L, Ridler K, Nichols TE et al. Thyroid hormone transporter genes and grey matter changes in patients with major depressive disorder and healthy controls. Psychoneuroendocrinology36(6), 929–934 (2011).
   PubMedGoogle Scholar
• Heuer H, Maier MK, Iden S et al. The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology146(4), 1701–1706 (2005).
   PubMed Web of Science ®Google Scholar
• Kassem NA, Deane R, Segal MB, Preston JE. Role of transthyretin in thyroxine transfer from cerebrospinal fluid to brain and choroid plexus. Am. J. Physiol. Regul. Integr. Comp. Physiol.291(5), R1310–R1215 (2006).
   Google Scholar
• Schreckenberger MF, Egle UT, Drecker S et al. Positron emission tomography reveals correlations between brain metabolism and mood changes in hyperthyroidism. J. Clin. Endocrinol. Metab.91(12), 4786–4791 (2006).
   PubMed Web of Science ®Google Scholar
• Zhu DF, Wang ZX, Zhang DR et al. fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism. Brain129(Pt 11), 2923–2930 (2006).
   PubMed Web of Science ®Google Scholar